Skip to main content

 

The Medical Advisory Board counsels HHMI leadership on scientific programs.

The board includes accomplished scientists and leaders of biomedical research institutions, who advise on:

  • long-range strategy for promoting biomedical research and science education;
  • proposals for new research programs, investigator competitions, and grants programs; 
  • scientific achievements and future potential of current investigators, including the evaluation of whether an investigator’s term of appointment should be renewed;
  • review of candidates for HHMI research programs; and
  • other matters concerning research programs and performance on which the president seeks counsel.

Members

Mary C. Beckerle, PhD
CEO and Director, Huntsman Cancer Institute
University of Utah

Vishva M. Dixit, MD
Vice President and Staff Scientist
Genentech, Inc.

Carol W. Greider, PhD
Distinguished Professor of Molecular, Cell, and Developmental Biology
University of California, Santa Cruz

Carol A. Gross, PhD
Professor, Department of Microbiology and Immunology
University of California, San Francisco

Edith Heard, PhD
Director General
European Molecular Biology Laboratory

Rowena G. Matthews, PhD
G. Robert Greenberg Distinguished University Professor Emeritus
University of Michigan

Eric N. Olson, PhD
Professor and Chair, Department of Molecular Biology
The University of Texas Southwestern Medical Center

Bruce W. Stillman, PhD, FRS
President and CEO
Cold Spring Harbor Laboratory

Craig B. Thompson, MD
Memorial Sloan Kettering Cancer Center

Richard W. Tsien, PhD
Chair and Druckenmiller Professor of Neuroscience
New York University School of Medicine

Fiona M. Watt, DPhil, FRS, FMedSci
King’s College London
Director, European Molecular Biology Organization

Detlef Weigel, PhD
Director
Max Planck Institute for Developmental Biology